Nifty

:

22147.90

Sensex

:

72943.68

-124.60 (-0.56%)
-456.10 (-0.62%)

Login

Nifty
Sensex

:
:

22147.90
72943.68

-124.60 (-0.56%)
-456.10 (-0.62%)

Gufic Biosciences Ltd.

Pharmaceuticals & Drugs - Domestic

Rating :

65/99

BSE: 509079 | NSE: GUFICBIO

Watchlist

NSE BSE

309.10

16-Apr-2024

Open
High
Low
Previous Close

302.70
311.00
302.10
303.10

Volume
Traded Value (lacs)
52 Week High
52 Week Low

53988
165.69
364.90
193.55

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

3,104.59
36.87
1

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

3,427.44
0.03%
6.05

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

18.83
14.51
12.30

EBITDA CAGR (%)

10 Years
5 Years
3 Years

27.32
23.97
9.92

PAT CAGR (%)

10 Years
5 Years
3 Years

34.03
29.43
21.69

P:E (Median)

8 Years
5 Years
3 Years

33.77
26.28
26.56

P:BV (Average)

8 Years
5 Years
3 Years

7.60
7.60
7.80

EV:EBITDA (Average)

8 Years
5 Years
3 Years

18.12
16.68
18.12

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated

Description Dec 23 Dec 22 Var% Sep 23 Sep 22 Var% Jun 23 Jun 22 Var% Mar 23 Mar 22 Var%
Net Sales 201.78 177.47 13.70% 214.87 174.83 22.90% 195.02 165.28 17.99% 173.04 162.19 6.69%
Expenses 165.32 144.08 14.74% 175.50 142.22 23.40% 159.54 132.10 20.77% 140.89 129.53 8.77%
EBITDA 36.45 33.39 9.16% 39.37 32.61 20.73% 35.48 33.18 6.93% 32.15 32.67 -1.59%
EBIDTM 18.07% 18.81% 18.32% 18.65% 18.19% 20.07% 18.58% 20.14%
Other Income 0.42 0.76 -44.74% 0.33 0.82 -59.76% 0.88 0.38 131.58% 0.62 0.04 1,450.00%
Interest 3.18 2.16 47.22% 4.46 1.61 177.02% 4.07 0.91 347.25% 2.92 1.31 122.90%
Depreciation 4.14 4.74 -12.66% 4.30 4.56 -5.70% 4.24 4.37 -2.97% 5.92 5.22 13.41%
PBT 29.56 27.25 8.48% 30.95 27.26 13.54% 28.05 28.28 -0.81% 23.93 26.18 -8.59%
Tax 7.30 6.91 5.64% 7.74 7.05 9.79% 7.43 7.23 2.77% 5.83 5.91 -1.35%
PAT 22.26 20.34 9.44% 23.21 20.21 14.84% 20.62 21.05 -2.04% 18.11 20.27 -10.66%
PATM 11.03% 11.46% 10.80% 11.56% 10.58% 12.74% 10.46% 12.49%
EPS 2.22 2.03 9.36% 2.31 2.02 14.36% 2.06 2.10 -1.90% 1.81 2.02 -10.40%

Description Dec 23 Dec 22 Var% Sep 23 Sep 22 Var% Jun 23 Jun 22 Var% Mar 23 Mar 22 Var%
Net Sales 201.78 0.00 0 214.87 0.00 0 0.00 0.00 0 0.00 0.00 0
Expenses 165.32 0.00 0 175.50 0.00 0 0.00 0.00 0 0.00 0.00 0
EBITDA 36.45 0.00 0 39.37 0.00 0 0.00 0.00 0 0.00 0.00 0
EBIDTM 18.07% 0.00% 18.32% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.42 0.00 0 0.33 0.00 0 0.00 0.00 0 0.00 0.00 0
Interest 3.18 0.00 0 4.46 0.00 0 0.00 0.00 0 0.00 0.00 0
Depreciation 4.14 0.00 0 4.30 0.00 0 0.00 0.00 0 0.00 0.00 0
PBT 29.56 0.00 0 30.95 0.00 0 0.00 0.00 0 0.00 0.00 0
Tax 7.30 0.00 0 7.74 0.00 0 0.00 0.00 0 0.00 0.00 0
PAT 22.26 0.00 0 23.21 0.00 0 0.00 0.00 0 0.00 0.00 0
PATM 11.03% 0.00% 10.80% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 2.22 0.00 0 2.39 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Right to Left

Description TTM Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Net Sales 784.71 690.62 779.16 487.70 378.84 350.77 305.58 245.52 202.20 151.55 123.01 Net Sales Growth 15.44% -11.36% 59.76% 28.74% 8.00% 14.79% 24.46% 21.42% 33.42% 23.20% Cost Of Goods Sold 383.84 295.46 368.49 226.12 156.47 161.37 128.58 107.42 90.84 73.47 55.61 Gross Profit 400.87 395.16 410.67 261.58 222.37 189.40 177.01 138.10 111.35 78.08 67.40 GP Margin 51.08% 57.22% 52.71% 53.64% 58.70% 54.00% 57.93% 56.25% 55.07% 51.52% 54.79% Total Expenditure 641.25 555.97 631.13 403.78 326.72 304.78 266.80 222.57 182.51 137.28 110.98 Power & Fuel Cost - 15.24 11.00 9.94 8.23 3.43 3.58 3.51 3.57 3.16 2.95 % Of Sales - 2.21% 1.41% 2.04% 2.17% 0.98% 1.17% 1.43% 1.77% 2.09% 2.40% Employee Cost - 86.73 85.61 66.22 58.59 46.85 44.62 41.03 31.95 19.23 12.25 % Of Sales - 12.56% 10.99% 13.58% 15.47% 13.36% 14.60% 16.71% 15.80% 12.69% 9.96% Manufacturing Exp. - 72.21 82.20 46.74 43.26 43.16 37.69 28.94 23.54 15.48 17.33 % Of Sales - 10.46% 10.55% 9.58% 11.42% 12.30% 12.33% 11.79% 11.64% 10.21% 14.09% General & Admin Exp. - 44.70 37.97 23.69 32.47 32.32 31.50 27.03 20.56 13.56 8.82 % Of Sales - 6.47% 4.87% 4.86% 8.57% 9.21% 10.31% 11.01% 10.17% 8.95% 7.17% Selling & Distn. Exp. - 31.74 28.38 17.87 17.35 11.36 13.26 9.11 8.19 8.78 12.41 % Of Sales - 4.60% 3.64% 3.66% 4.58% 3.24% 4.34% 3.71% 4.05% 5.79% 10.09% Miscellaneous Exp. - 9.88 17.48 13.20 10.36 6.29 7.57 5.53 3.85 3.61 12.41 % Of Sales - 1.43% 2.24% 2.71% 2.73% 1.79% 2.48% 2.25% 1.90% 2.38% 1.31% EBITDA 143.45 134.65 148.03 83.92 52.12 45.99 38.78 22.95 19.69 14.27 12.03 EBITDA Margin 18.28% 19.50% 19.00% 17.21% 13.76% 13.11% 12.69% 9.35% 9.74% 9.42% 9.78% Other Income 2.25 2.57 3.10 3.73 5.79 4.17 2.86 1.44 0.66 0.57 0.63 Interest 14.63 8.22 5.37 13.63 13.91 10.16 8.88 6.34 6.20 4.46 3.92 Depreciation 18.60 22.28 18.93 16.31 13.86 4.65 4.40 3.68 3.79 3.85 2.47 PBT 112.49 106.72 126.84 57.71 30.13 35.35 28.37 14.37 10.36 6.53 6.27 Tax 28.30 27.02 31.00 13.48 7.44 13.41 13.48 5.35 3.03 2.37 2.01 Tax Rate 25.16% 25.32% 24.44% 23.36% 24.69% 37.93% 44.99% 37.23% 29.25% 36.29% 32.06% PAT 84.20 79.70 95.84 44.23 22.69 21.94 16.48 9.02 7.32 4.16 4.26 PAT before Minority Interest 84.20 79.70 95.84 44.23 22.69 21.94 16.48 9.02 7.32 4.16 4.26 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 10.73% 11.54% 12.30% 9.07% 5.99% 6.25% 5.39% 3.67% 3.62% 2.74% 3.46% PAT Growth 2.85% -16.84% 116.69% 94.93% 3.42% 33.13% 82.71% 23.22% 75.96% -2.35% EPS 8.39 7.95 9.56 4.41 2.26 2.19 1.64 0.90 0.73 0.41 0.42

Results Balance Sheet

Standalone Figures in Rs. Crores

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Shareholder's Funds 347.81 269.12 173.44 129.32 75.35 54.14 37.33 33.96 27.10 26.21 Share Capital 9.69 9.69 9.69 9.69 7.78 7.78 7.74 7.74 7.74 7.74 Total Reserves 338.11 259.42 163.74 119.63 67.56 46.35 29.59 26.22 19.36 18.47 Non-Current Liabilities 224.18 65.88 54.96 37.79 17.16 12.54 9.16 14.56 16.58 24.63 Secured Loans 190.68 47.98 35.43 19.52 11.25 4.43 3.20 4.84 8.62 10.17 Unsecured Loans 0.00 0.00 0.00 0.03 0.06 3.89 3.42 2.82 2.88 4.71 Long Term Provisions 13.29 12.39 10.23 7.93 1.86 2.26 2.29 1.39 1.41 1.35 Current Liabilities 288.21 186.40 163.66 325.60 217.72 168.55 128.18 103.68 83.61 60.31 Trade Payables 130.26 140.95 111.21 117.07 77.81 75.98 43.74 52.62 49.53 31.80 Other Current Liabilities 38.82 33.30 29.98 22.99 16.28 17.24 20.75 14.10 13.01 11.28 Short Term Borrowings 111.76 6.60 16.32 93.10 84.69 69.17 46.97 32.28 17.90 14.77 Short Term Provisions 7.37 5.55 6.15 92.44 38.95 6.16 16.73 4.67 3.16 2.47 Total Liabilities 860.20 521.40 392.06 492.71 310.23 235.23 174.67 152.20 127.29 111.15 Net Block 159.57 115.17 99.97 82.58 24.45 22.85 21.96 22.15 25.11 30.23 Gross Block 246.31 179.65 148.64 114.98 37.19 31.00 25.65 51.31 50.81 48.46 Accumulated Depreciation 86.74 64.48 48.67 32.40 12.74 8.15 3.68 29.17 25.71 18.23 Non Current Assets 396.08 200.65 131.48 133.58 46.34 37.02 31.42 32.69 35.81 41.84 Capital Work in Progress 169.59 40.87 13.40 30.61 9.63 2.05 0.04 0.00 0.00 0.00 Non Current Investment 0.78 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01 Long Term Loans & Adv. 64.35 43.65 17.12 18.54 10.16 8.73 7.60 9.01 9.17 11.32 Other Non Current Assets 1.80 0.95 0.98 1.84 2.09 3.38 1.82 1.52 1.52 0.28 Current Assets 464.11 320.75 260.58 359.13 263.89 198.20 143.25 119.51 91.48 69.30 Current Investments 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 183.46 115.57 94.40 122.46 94.28 94.20 63.02 50.26 36.80 26.12 Sundry Debtors 205.47 151.55 124.50 106.97 103.18 80.80 52.12 56.23 33.38 28.21 Cash & Bank 46.69 26.57 13.18 16.37 7.59 7.50 5.64 6.16 6.21 2.54 Other Current Assets 28.50 0.86 0.69 0.84 58.84 15.71 22.47 6.86 15.08 12.44 Short Term Loans & Adv. 26.71 26.21 27.81 112.48 57.74 15.33 21.38 6.10 12.45 9.60 Net Current Assets 175.90 134.35 96.92 33.53 46.17 29.66 15.07 15.84 7.87 8.99 Total Assets 860.19 521.40 392.06 492.71 310.23 235.22 174.67 152.20 127.29 111.14

Cash Flow

Standalone Figures in Rs. Crores

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Cash From Operating Activity -26.59 106.24 87.25 47.10 5.21 -4.82 -4.13 -4.32 11.15 10.87 PBT 106.72 126.84 57.71 30.13 35.35 29.95 14.37 11.19 6.53 6.27 Adjustment 29.64 23.18 30.79 24.63 13.35 12.07 9.75 8.84 8.19 6.27 Changes in Working Capital -135.25 -10.72 8.15 2.48 -33.52 -30.40 -23.70 -21.31 -1.60 -0.19 Cash after chg. in Working capital 1.11 139.30 96.65 57.24 15.18 11.63 0.42 -1.28 13.12 12.36 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -27.70 -33.06 -9.40 -10.14 -9.98 -16.44 -4.55 -2.65 -1.96 -1.49 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.38 0.00 0.00 Cash From Investing Activity -190.73 -94.59 -6.69 -42.53 -12.99 -8.84 -4.69 -0.51 -2.39 -2.78 Net Fixed Assets -195.38 -58.48 -16.45 -98.77 -13.77 -7.36 25.62 -0.50 -2.35 -2.89 Net Investments -0.77 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Others 5.42 -36.11 9.76 56.24 0.78 -1.48 -30.31 -0.01 -0.04 0.11 Cash from Financing Activity 234.31 -6.24 -78.62 -4.21 7.71 14.40 7.41 4.78 -5.09 -6.82 Net Cash Inflow / Outflow 16.99 5.41 1.94 0.37 -0.08 0.75 -1.41 -0.05 3.67 1.26 Opening Cash & Equivalents 11.61 6.20 4.26 3.90 3.74 2.99 4.28 6.21 2.54 1.28 Closing Cash & Equivalent 28.60 11.61 6.20 4.26 3.66 3.74 2.87 6.16 6.21 2.54

Financial Ratios

Standalone

Right to Left

Description Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14
Book Value (Rs.) 35.88 27.76 17.89 13.34 9.68 6.96 4.83 4.39 3.50 3.39 ROA 11.54% 20.98% 10.00% 5.65% 8.04% 8.04% 5.52% 5.24% 3.49% 4.25% ROE 25.84% 43.31% 29.22% 22.17% 33.89% 36.03% 25.31% 23.99% 15.60% 17.55% ROCE 23.23% 47.29% 30.05% 21.01% 29.65% 34.10% 24.26% 24.24% 18.38% 17.45% Fixed Asset Turnover 3.76 5.17 3.94 5.14 10.57 11.21 6.77 4.19 3.22 2.86 Receivable days 81.36 59.40 81.43 97.98 93.16 76.39 75.93 76.38 70.29 67.55 Inventory Days 68.14 45.18 76.30 101.05 95.44 90.36 79.39 74.21 71.80 64.60 Payable days 167.52 124.89 184.25 115.05 115.32 80.93 87.99 110.87 119.47 95.34 Cash Conversion Cycle -18.02 -20.30 -26.52 83.98 73.27 85.82 67.32 39.73 22.62 36.81 Total Debt/Equity 0.90 0.23 0.32 0.90 1.30 1.47 1.52 1.26 1.21 1.27 Interest Cover 13.98 24.64 5.23 3.17 4.48 4.37 3.27 2.67 2.46 2.60

Top Investors:

motilal oswal financial services ltd

jagdish n master

motilal oswal small cap fund

investor education and protection fund (iepf)

Annual Reports:

News Update:

Gufic Biosciences incorporates Wholly Owned Subsidiary
4th Apr 2024, 10:40 AM

‘Veira Life FZE’ shall carry on the business of marketing, distribution and sale of pharmaceutical products
Read More
Gufic Biosciences - Quarterly Results
14th Feb 2024, 17:57 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback